Predict your next investment

pgxhealth.com

See what CB Insights has to offer

About PGxHealth

This division of Clinical Data, Inc. has extensive experience and capabilities in the development, clinical validation and delivery of genetic tests that assist providers in targeting efficacious and safe drugs for their patients. It has branded its genetic tests based on these proprietary genetic markers as Therapeutic Diagnostics(TM).

PGxHealth Headquarter Location

5 Science Park # 6

New Haven, Connecticut, 06511-1989,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PGxHealth

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find PGxHealth in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest PGxHealth News

Trovis Pharmaceuticals LLC formerly known as PGxHealth LLC Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 26, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 01:34 EST 26 Nov 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC since January 2007. Key Findings Provides intelligence on Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC and its subsidiaries since 2007. Information about key financial and legal advisors for Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Trovis Pharmaceuticals, LLC formerly known as PGxHealth, LLC's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

PGxHealth Acquisitions

1 Acquisition

PGxHealth acquired 1 company. Their latest acquisition was Adenosine Therapeutics on August 15, 2008.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/15/2008

Series C

$991

$15M

Acquired

Date

8/15/2008

Investment Stage

Series C

Companies

Valuation

$991

Total Funding

$15M

Note

Acquired

Sources

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.